Our 150-year history tells a story of growth, of innovation – and of doing the right thing. We focus on patients challenged with devastating conditions and we provide highly effective treatments to underserved patient populations.
As a specialty pharmaceuticals leader today, our strong financial position is built on our “acquire to invest” business model. Areas of focus include autoimmune and rare disease specialties like neurology, rheumatology, nephrology, pulmonology and opthalmology; and in the hospital suite, immunotherapy and neonatal respiratory critical care therapies, analgesics and hemostasis products. We also have a broad portfolio of generic prescription medicines, as well as active pharmaceutical ingredients. To find out more, visit Mallinckrodt.com
Mallinckrodt is big enough to be global, small enough to be nimble, and bold enough to take on complex challenges every day. Our five Cultural Hallmarks guide our work and serve as a foundation for our success. Employees are Accountable, Competitive, Collaborative, High Performing and Trustworthy.
We are proud of our unique products and strong development pipeline, and we’re committed to building our portfolio with strategic product acquisitions. We recognise that our momentum is fuelled by our people. Mallinckrodt teams constantly rise to meet new challenges as they work to uncover solutions for patients challenged with devastating conditions.
It’s a fast-paced environment where you can stretch your talents, expand your expertise and grow professionally. If you’re a talented and driven individual with relevant experience and a strong desire to enact change throughout the world, Mallinckrodt offers unique opportunities in a company with incredible momentum.
